Literature DB >> 2381502

Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue.

E Nilsson1, I Alafuzoff, K Blennow, K Blomgren, C M Hall, I Janson, I Karlsson, A Wallin, C G Gottfries, J O Karlsson.   

Abstract

The Ca2(+)-dependent neutral proteases calpain I and II as well as their specific inhibitor, calpastatin, were isolated from normal and Alzheimer-degenerated frozen human brain tissue. In the Alzheimer group calpain I activity was higher in cortex than in mesencephalon. The calpastatin activity was lower in cortex in both groups. This may implicate a higher Ca2(+)-dependent proteolysis in cortex compared to mesencephalon. In the Alzheimer group the cortical calpain II level decreased with an increasing degree of neuropathological changes. In the control group, the level of calpastatin decreased as the number of plaques and tangles increased. Evidence was obtained for a correlation of net calpain activity and the extent of neuropathological changes in cortex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2381502     DOI: 10.1016/0197-4580(90)90009-o

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells.

Authors:  The Minh Vo; Rebecca Burchett; Miranda Brun; Elizabeth A Monckton; Ho-Yin Poon; Roseline Godbout
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

2.  Calcium-activated neutral protease activities in brain trauma.

Authors:  E Arrigoni; F Cohadon
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

3.  Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.

Authors:  A Favit; M Grimaldi; T J Nelson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Calpain activity in adult and aged human brain regions.

Authors:  M Banay-Schwartz; T DeGuzman; M Palkovits; A Lajtha
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

5.  Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.

Authors:  Xiao-Xin Yan; Andreas Jeromin; A Jeromin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-06

6.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.

Authors:  K Saito; J S Elce; J E Hamos; R A Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Calpastatin in erythrocytes of young and old individuals.

Authors:  N Schwarz-Benmeir; T Glaser; S Barnoy; N S Kosower
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 8.  The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states.

Authors:  P W Vanderklish; B A Bahr
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

9.  Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.

Authors:  Mala V Rao; Panaiyur S Mohan; Corrinne M Peterhoff; Dun-Sheng Yang; Stephen D Schmidt; Philip H Stavrides; Jabbar Campbell; Yuanxin Chen; Ying Jiang; Peter A Paskevich; Anne M Cataldo; Vahram Haroutunian; Ralph A Nixon
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  Calpain processing of brain microtubules from the Atlantic cod, Gadus morhua.

Authors:  M Billger; E Nilsson; J O Karlsson; M Wallin
Journal:  Mol Cell Biochem       Date:  1993-04-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.